Timing. Relevance. Relationships.
Fundz is the only platform that reads more than a dozen real‑time signals all day, every day, so you know about new funding, new executives and new contracts within minutes of them happening, not days or weeks later like the databases you’re used to. It then combines the signals on each company, scores every company against what you offer, and weaves in your own network, so you discover new accounts first and work existing ones better.
Each morning you get the ones worth your time right now: who to reach, why now, and who you already know there. Now it answers in Claude too: ask for today’s leads, then write the note in the same window.
Trusted by
Amount Raised
$50 Million
Round Type
Debt Financing
New YorkBiotechnologyPharmaceuticalBiopharmaInvestors
Description
Fortress Biotech, Inc. repaid the remaining $15 million principal under its senior secured credit agreement with Oaktree Fund Administration, LLC on September 30, 2026. This repayment included accrued interest and fees, resulting in the release of all liens against the company's assets. The agreement was initially executed on July 25, 2024, and was aimed at supporting Fortress's financial operations
Fundz sees it the moment Fortress Biotech, Inc. raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Fortress Biotech, Inc. raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.